Category Archives: Healthcare

The PRES. of VistaGen Therapeutics (NASDAQ: VTGN) is Buying Shares

Yesterday, the PRES. of VistaGen Therapeutics (VTGN – Research Report), Ralph Snodgrass, bought shares of VTGN for $5,100. Following this transaction Ralph Snodgrass’ holding in the company was increased by 23.91% to a total of $25.49K. See today’s analyst top

Cowen & Co. Remains a Buy on Bluebird Bio (BLUE)

In a report released yesterday, Yaron Werber from Cowen & Co. maintained a Buy rating on Bluebird Bio (BLUE – Research Report). The company’s shares closed last Monday at $73.68, close to its 52-week low of $72.02. According to TipRanks.com,

The SVP, Manuf & Sup Chn of Boston Scientific (NYSE: BSX) is Selling Shares

Today, the SVP, Manuf & Sup Chn of Boston Scientific (BSX – Research Report), John Bradley Sorenson, sold shares of BSX for $204.4K. Following John Bradley Sorenson’s last BSX Sell transaction on August 14, 2019, the stock climbed by 0.9%.

Analysts Offer Insights on Healthcare Companies: Amicus (NASDAQ: FOLD) and Crinetics Pharmaceuticals (NASDAQ: CRNX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amicus (FOLD – Research Report) and Crinetics Pharmaceuticals (CRNX – Research Report) with bullish sentiments. Amicus (FOLD) H.C. Wainwright analyst Debjit Chattopadhyay

H.C. Wainwright Keeps Their Hold Rating on T2 Biosystems (TTOO)

H.C. Wainwright analyst Yi Chen reiterated a Hold rating on T2 Biosystems (TTOO – Research Report) today. The company’s shares closed last Monday at $1.78. According to TipRanks.com, Chen has 0 stars on 0-5 star ranking scale with an average

Analysts Are Bullish on Top Healthcare Stocks: Arch Therapeutics (ARTH), Oragenics (OGEN)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arch Therapeutics (ARTH – Research Report), Oragenics (OGEN – Research Report) and Seres Therapeutics (MCRB – Research Report) with bullish sentiments. Arch